What type of study is this?

This is a Human Clinical Trial study.

What question did this study set out to answer?

This research aims to present a new guideline for integrating AI and robotics into oncology clinical trials.

March 14, 2026Open Access

View Full Paper

Adaption: ICH Harmonised Guideline, End-to-End Physical AI Oncology Clinical Trial Unification

Key Points

This research aims to present a new guideline for integrating AI and robotics into oncology clinical trials.
Draft revision of the ICH E6(R3) Guideline for Good Clinical Practice.
Incorporation of scalable AI and robotics workflows into clinical trial practices.
Introduced a new framework for unifying oncology clinical trials through AI and robotic enhancements.
Clarified the legal usage and copyright considerations for the original ICH guideline.

Abstract

The end-to-end physical ai oncology clinical trial unification guidance is a replacement draft to the International Council for Harmonisation (ICH) E6(R3) Guideline for Good Clinical Practice (GCP). This new adaption incorporates scalable AI and robotics workflows into clinical trials. The original ICH E6(R3) document is protected by copyright and may be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license, as detailed in Legal Notice. This current work is not endorsed or sponsored by ICH.

AIに質問

Bookmark

View Full Paper

AIに質問

Bookmark

View Full Paper

Adaption: ICH Harmonised Guideline, End-to-End Physical AI Oncology Clinical Trial Unification

Key Points

Abstract

Cite This Study

Also Consider

Also Consider